DEF: Royce Micro-Cap Trust Sets Annual Meeting for Oct 8

Royce Micro-Cap Trust, Inc. announces its Annual Meeting of Stockholders on October 8, 2025, to elect two Class II Directors and address other business.

Summary

• The Annual Meeting of Stockholders will be held on Wednesday, October 8, 2025, at 3:30 p.m. Eastern Time, at the Fund's offices in New York.
• The primary purpose of the meeting is to elect two Class II Directors, Patricia W. Chadwick and Michael K. Shields, for a three-year term expiring at the Fund's 2028 Annual Meeting.
• The record date for determining stockholders entitled to vote is August 5, 2025.
• The Board of Directors consists of seven Directors, with six currently serving as Independent Directors, exceeding the 40% requirement of the Investment Company Act.
• Christopher C. Grisanti has been designated as the lead Independent Director.
• The Audit Committee and Nominating Committee are composed solely of Independent Directors.
• Independent Directors received an annual rate of $10,000 for serving on the Board, plus $450 for each Board meeting attended for the year ended December 31, 2024.
• Christopher C. Grisanti received an additional $1,475 as lead Independent Director, and Julia W. Poston received an additional $984 as Chair of the Audit Committee for the year ended December 31, 2024.
• Aggregate compensation from the Fund Complex for Independent Directors for the year ended December 31, 2024, ranged from $223,500 to $724,250 (for G. Peter OBrien, who also served on Legg Mason Funds).
• As of the record date, 52,592,863 shares of Common Stock were outstanding.
• Cede & Co. was the record owner of 99.40% (52,275,768 shares) of outstanding Common Stock.
• Known beneficial owners of 5% or more include Morgan Stanley (6.0% as of March 31, 2025) and First Trust Portfolios L.P. (6.40% as of December 31, 2023).
• All Directors and officers, as a group, beneficially owned less than 1% of the Fund's outstanding shares.
• Audit fees paid to PricewaterhouseCoopers LLP (PWC) were $42,223 for 2024 and $40,992 for 2023.
• Tax fees paid to PWC were $11,509 for 2024 and $11,173 for 2023.
• The Audit Committee reviewed the Fund's financial statements as of December 31, 2024, and for the fiscal year then ended, with no material concerns reported.

Sentiment

Score: 6

Explanation: The filing is largely procedural, detailing standard corporate governance and director elections. The ongoing litigation regarding the Maryland Control Share Acquisition Act introduces a degree of uncertainty, but the overall sentiment is neutral to slightly positive due to robust independent director oversight and no immediate negative financial news.

Positives

• The Board maintains a strong independent director representation, with six out of seven directors being independent, ensuring robust oversight.
• The Board members possess extensive experience in finance, investment, accounting, and business, contributing diverse expertise.
• Key committees, including the Audit Committee and Nominating Committee, are composed entirely of independent directors, enhancing governance integrity.
• Two Audit Committee Financial Experts, Patricia W. Chadwick and Julia W. Poston, are identified, ensuring high-level financial oversight.
• The Board and its committees have access to independent legal counsel and the ability to engage other experts, supporting informed decision-making.
• The Audit Committee conducted a review of the 2024 financial statements and reported no material concerns, indicating sound financial reporting.

Risks

• The Fund is indirectly involved in ongoing litigation concerning the Maryland Control Share Acquisition Act (MCSAA), where the U.S. Supreme Court granted certiorari on June 30, 2025, to resolve a circuit split regarding private parties' implied right of action to enforce provisions of the Investment Company Act of 1940. This could impact the Fund's corporate governance structure or ability to rely on certain exemptive rules.
• There is a risk of the Annual Meeting being adjourned if sufficient votes are not received to approve the Director nominees.

Future Outlook

The filing primarily concerns the upcoming annual meeting and corporate governance matters. It does not provide forward-looking statements or guidance on the Fund's financial performance or strategic direction beyond the election of directors and the ongoing litigation related to the Maryland Control Share Acquisition Act.

Industry Context

This filing is a standard proxy statement for a closed-end investment company, focusing on corporate governance, director elections, and compliance with SEC regulations. The ongoing litigation concerning the Maryland Control Share Acquisition Act (MCSAA) highlights a broader legal challenge faced by some closed-end funds regarding anti-takeover provisions and the Investment Company Act of 1940. This issue affects the corporate governance landscape for similar investment vehicles, as the Supreme Court's decision could clarify the scope of private rights of action under the Investment Company Act.

Management Changes

Corporate Governance

Legal Proceedings

• Saba Capital Master Funds., Ltd., et al. v. Clearbridge Energy Midstream Opportunity Fund, Inc., et al., No. 1:23-cv-05568 (S.D.N.Y.): Litigation filed on June 29, 2023, against Royce Global Trust (RGT) and other funds (but not Royce Micro-Cap Trust, Inc. directly) challenging the election to opt into the Maryland Control Share Acquisition Act (MCSAA). The U.S. District Court for the Southern District of New York declared the control share resolutions in violation of the Investment Company Act and ordered rescission on January 4, 2024. The Second Circuit affirmed this judgment on June 26, 2024. On June 30, 2025, the U.S. Supreme Court granted certiorari to review the Second Circuit's judgment, specifically to resolve a circuit split over whether private parties have an implied right of action to enforce certain provisions of the Investment Company Act of 1940.

Related Party Transactions

• Christopher D. Clark, an interested person due to his positions as CEO, President, and Co-Chief Investment Officer of Royce (the Fund's investment adviser), serves as a Director and President of the Fund and is a member of the Distribution Committee.
• Officers and employees of the Fund and/or Royce & Associates, LP may solicit proxies for the Annual Meeting.
• PricewaterhouseCoopers LLP (PWC) provided non-audit services to Royce and its affiliates, totaling $11,509 in 2024 and $11,173 in 2023, which the Audit Committee determined to be compatible with maintaining PWC's independence.

Stakeholder Impact

• Shareholders will participate in the election of directors, influencing the future composition and oversight of the Board. The outcome of the MCSAA litigation could affect shareholder voting rights and potential control share acquisitions.
• Management and Directors will continue their roles, with the re-election of directors ensuring continuity. The resolution of the MCSAA litigation may influence future corporate governance practices.
• Royce & Associates, LP, as the investment adviser, will continue its role, with its officers serving on the Fund's board and in officer capacities.

Next Steps

• Stockholders are encouraged to vote on Director nominees by October 7, 2025.
• The Annual Meeting of Stockholders will be held on October 8, 2025.
• The Semiannual Report to Stockholders for the six-month period ended June 30, 2025, will be made available in late August 2025.
• Stockholder proposals intended for the Fund's 2026 Annual Meeting must be received by April 17, 2026, for inclusion in the Proxy Statement.
• Advance notice for any stockholder nominations or other business for the 2026 Annual Meeting must be received between April 24, 2026, and May 24, 2026.
• The U.S. Supreme Court will resolve a circuit split regarding the Maryland Control Share Acquisition Act litigation.

Key Dates

Recommendation

This filing is a standard proxy statement for an annual meeting, primarily focused on corporate governance and director elections. It does not contain new financial performance data or strategic announcements that would warrant a 'buy' or 'sell' recommendation. The ongoing litigation regarding the Maryland Control Share Acquisition Act introduces a degree of uncertainty, but its direct impact on the Fund's operational performance or immediate valuation is not clear from this document. Given the procedural nature and lack of new material financial information, a 'hold' recommendation is appropriate, advising investors to maintain their current position while monitoring future developments, particularly regarding the Supreme Court case.

Keywords

Royce Micro-Cap Trust, SEC filing, proxy statement, corporate governance, board of directors, annual meeting, stockholder vote, investment company, micro-cap, financial reporting, audit committee, nominating committee, Maryland Control Share Acquisition Act, litigation, Investment Company Act of 1940